Hap Trading, LLC Citius Pharmaceuticals, Inc. Transaction History
Hap Trading, LLC
- $1.15 Trillion
- Q4 2024
A detailed history of Hap Trading, LLC transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Hap Trading, LLC holds 33,600 shares of CTXR stock, worth $25,200. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33,600Holding current value
$25,200% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CTXR
# of Institutions
6Shares Held
2.04MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY1.81MShares$1.35 Million0.0% of portfolio
-
Key Bridge Compliance, LLC Covington, KY154KShares$115,5970.03% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ40.3KShares$30,2120.0% of portfolio
-
American Portfolios Advisors Holbrook, NY4KShares$3,0000.0% of portfolio
-
Clear Perspectives Financial Planning, LLC Cincinnati, OH400Shares$3000.0% of portfolio
About Citius Pharmaceuticals, Inc.
- Ticker CTXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 146,130,000
- Market Cap $110M
- Description
- Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...